Latin America Business Today
SEE OTHER BRANDS

Fresh news on business and economy in Latin America

Latin America Business Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Business Today.

Press releases published on July 31, 2025

Exponent Reports Second Quarter 2025 Financial Results

Exponent Reports Second Quarter 2025 Financial Results

MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2025 ended July 4, 2025. “Second quarter revenues were flat but exceeded expectations, reflecting our …

Exponent Declares Regular Quarterly Dividend for Q3 2025

Exponent Declares Regular Quarterly Dividend for Q3 2025

MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on September 19, 2025, to all common …

Cemtrex Acquires $1 Million in Solana, Citing Structural Mispricing; Targets $10 Million Crypto Treasury Reserve

Cemtrex Acquires $1 Million in Solana, Citing Structural Mispricing; Targets $10 Million Crypto Treasury Reserve

Hauppauge, NY, July 31, 2025 (GLOBE NEWSWIRE) --  Cemtrex Inc. (Nasdaq: CETX), a technology company focused on intelligent security systems and industrial services, today announced it has acquired approximately $1 million worth of Solana (SOL) as part of a …

Cavco Industries Reports Fiscal 2026 First Quarter Results

Cavco Industries Reports Fiscal 2026 First Quarter Results

PHOENIX, July 31, 2025 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) ("we," "our," the "Company" or "Cavco") today announced financial results for the first fiscal quarter ended June 28, 2025. Quarterly Highlights Net revenue was $557 million, …

Nature's Sunshine Reports Second Quarter 2025 Results

Nature's Sunshine Reports Second Quarter 2025 Results

LEHI, Utah, July 31, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the second quarter ended June 30, …

LPL Financial Announces Second Quarter 2025 Results

LPL Financial Announces Second Quarter 2025 Results

Key Financial Results: Net Income was $273 million, translating to diluted earnings per share ("EPS") of $3.40, up 5% from a year ago Adjusted EPS* increased 16% year-over-year to $4.51 Gross profit* increased 21% year-over-year to $1,304 million Core G…

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Year-over-year revenue grows 10%, operating profit up 19%, non-GAAP operating profit up 19% Operating cash flow of $539 million Quarterly dividend increases 13% to $0.60 per share Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. …

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include the following: …

LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia

LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once daily solution to treat blurry near vision with proven …

Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call

Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call

RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets close on …

CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025

CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025

- Conference Call Scheduled for Thursday, August 14, 2025 at 4:30 pm ET - SARATOGA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial …

NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering

NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (“NCS” or the “Company”) today announced that it has acquired ResMetrics LLC (“ResMetrics”), a leading provider of chemical tracer diagnostics services used by oil and …

Orchestra BioMed Announces Proposed Public Offering

Orchestra BioMed Announces Proposed Public Offering

NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …

BJ’s Restaurants, Inc. Reports Fiscal Second Quarter 2025 Results

BJ’s Restaurants, Inc. Reports Fiscal Second Quarter 2025 Results

HUNTINGTON BEACH, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ: BJRI) today reported financial results for its fiscal 2025 second quarter ended Tuesday, July 1, 2025. Fiscal Second Quarter 2025 Compared to Second Quarter 2024 …

WillScot Reports Second Quarter 2025 Results and Updates 2025 Full Year Outlook

WillScot Reports Second Quarter 2025 Results and Updates 2025 Full Year Outlook

PHOENIX, July 31, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced second quarter 2025 results, including key performance highlights, …

Casella Waste Systems, Inc. Announces Second Quarter 2025 Results

Casella Waste Systems, Inc. Announces Second Quarter 2025 Results

RUTLAND, Vt., July 31, 2025 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (NASDAQ: CWST), a regional solid waste, recycling and resource management services company, today reported its financial results for the three and six-month periods ended June 30, …

StoneX Completes Acquisition of R.J. O’Brien, Becoming the Largest Non-Bank FCM in the United States and Enhancing Global Multi-Asset Capabilities

StoneX Completes Acquisition of R.J. O’Brien, Becoming the Largest Non-Bank FCM in the United States and Enhancing Global Multi-Asset Capabilities

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- StoneX Group Inc. (NASDAQ: SNEX) (“StoneX” or the “Company”), today announced the successful completion of its previously announced acquisition of R.J. O’Brien (“RJO”), the oldest independent futures brokerage in …

Monolithic Power Systems Announces Results for the Second Quarter Ended June 30, 2025

Monolithic Power Systems Announces Results for the Second Quarter Ended June 30, 2025

KIRKLAND, Wash., July 31, 2025 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a fabless global company that provides high-performance, semiconductor-based power electronics solutions, today announced financial results for the …

Monolithic Power Systems Provides Earnings Commentary for the Quarter Ended June 30, 2025

Monolithic Power Systems Provides Earnings Commentary for the Quarter Ended June 30, 2025

KIRKLAND, Wash., July 31, 2025 (GLOBE NEWSWIRE) -- MPS will report its results after the market closes on July 31, 2025 and host a question-and-answer webinar at 2:00 p.m. PT / 5:00 p.m. ET. The live event will be held via a Zoom webcast, which can be …

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

• Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement  • Medtronic to invest $10 million in an equity private placement and an …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions